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Abstract
Innate immunity plays a pivotal role in obesity-induced low-grade inflammation originating
from adipose tissue. Key receptors of the innate immune system including Toll-like recep-
tors-2 and -4 (TLRs) are triggered by nutrient excess to promote inflammation. The role of
other TLRs in this process is largely unknown. In addition to double-stranded viral mRNA,
TLR-3 can also recognize mRNA from dying endogenous cells, a process that is frequently
observed within obese adipose tissue. Here, we identified profound expression of TLR-3 in
adipocytes and investigated its role during diet-induced obesity. Human adipose tissue bi-
opsies (n=80) and an adipocyte cell-line were used to study TLR-3 expression and function.
TLR-3-/- and WT animals were exposed to a high-fat diet (HFD) for 16 weeks to induce obe-
sity. Expression of TLR-3 was significantly higher in human adipocytes compared to the
non-adipocyte cells part of the adipose tissue. In vitro, TLR-3 expression was induced dur-
ing differentiation of adipocytes and stimulation of the receptor led to elevated expression of
pro-inflammatory cytokines. In vivo, TLR-3 deficiency did not significantly influence HFD-
induced obesity, insulin sensitivity or inflammation. In humans, TLR-3 expression in adipose
tissue did not correlate with BMI or insulin sensitivity (HOMA-IR). Together, our results dem-
onstrate that TLR-3 is highly expressed in adipocytes and functionally active. However,
TLR-3 appears to play a redundant role in obesity-induced inflammation and
insulin resistance.
Introduction
Obesity is a worldwide problem that profoundly affects global health [1]. Obesity is associated
with type 2 diabetes mellitus, cardiovascular disease, hepatic steatosis and obesity-related
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cancers [2]. Development of obesity leads to morphological and functional changes in adipose
tissue. Adipocytes become hypertrophic and immune cells, such as macrophages [3,4], T- and
B-cells [5], infiltrate into the adipose tissue [6]. This inflammatory trait is associated with insu-
lin resistance and subsequently type 2 diabetes mellitus. Much remains to be learned about the
factors that initiate and propagate adipose tissue inflammation.
An inflammatory response is initiated when exogenous (pathogen associated molecular pat-
tern, PAMP) or endogenous (danger associated molecular pattern, DAMP) ligands are recog-
nized by a pattern recognition receptor (PRR). Activation of PRRs triggers intracellular
signalling cascades, eventually leading to production of chemokines and pro-inflammatory cy-
tokines and recruitment and activation of immune cells. TNFα, interleukin (IL)-1β, IL-6 and
IL-8 are the best-known cytokines involved in adipose tissue inflammation and the subsequent
development of insulin resistance [7–9]. Potential DAMPs in adipose tissue, released by dying
adipocytes or certain lipids, are present in increased concentrations in obesity [10]. It is there-
fore of high interest to identify which pattern recognition receptors mediate the link between
obesity and adipose tissue inflammation.
Toll-like receptors (TLRs) are a large class of transmembrane PPRs and well known for
their role in inflammatory signalling during infection and inflammation [11]. In humans, ten
members of the TLR-family have been described [12]. Amongst these, TLR-2 and TLR-4 have
emerged as important regulators of pro-inflammatory signalling in response to saturated fatty
acids [13–16], thereby mediating at least part of the HFD-induced adipose tissue inflammation
[17]. In contrast, the role of other TLRs in adipose tissue inflammation remains
largely unknown.
In the present study we screened the expression of all TLR-family members in adipose tis-
sue. Remarkably, we identified TLR-3 as being highly expressed in the adipocytes, in contrast
to other TLRs that were mainly present in the stromal vascular fraction of the adipose tissue.
Interestingly, TLR-3 can bind mRNA that is released from dying cells [18] aside from double-
stranded viral mRNA [19], hence may be activated by apoptotic adipocytes that are frequently
observed within obese adipose tissue [20]. Therefore, we were prompted to investigate the role
of TLR-3 in adipose tissue inflammation, using complementary in-vitro and in-vivo experi-
mental models, as well as human adipose tissue biopsies.
Methods
Human subjects
Paired subcutaneous (SAT) and visceral adipose tissue (omentum) (VAT) samples were ob-
tained according a standardized procedure from 4 patients (two females and two males) to in-
vestigate expression of TLRs in mature adipocytes (MA) versus the stromal vascular fraction
(SVF). Tissue biopsies were taken during elective cholecystectomy. Subjects were between 40–
60 years old with a body mass index (BMI) of 25–28 kg/m2. Subjects were normoglycemic.
Metabolic, endocrine and chronic and/or acute inflammatory diseases were excluded.
Moreover, adipose tissue samples were obtained from 80 healthy human subjects who were
recruited through advertisements in local newspapers. We included healthy subjects between
40 and 70 years old (see S1 Table). Subcutaneous adipose tissue biopsies were obtained under
local anesthesia by needle biopsies 6–10 cm lateral to the umbilicus. Samples were taken after
an overnight fast. TLR-3 expression was measured in the adipose tissue biopsies of all subjects.
Subsequently, metabolic parameters were compared to TLR-3 expression: BMI (<25, n = 33;
BMI>30, n = 18), Homeostatic model assessment for insulin resistance (HOMA-IR) levels
(<2, n = 40;>2 n = 26, hsCRP plasma levels (<0.5mg/l, n = 19;>1.7mg/l, n = 19) and number
of crown-like structures in the adipose tissue (no, n = 53; yes, n = 19). Furthermore,
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associations were made between adipose tissue TLR-3 expression and the lowest and highest
quartiles, with respect to mRNA expression levels, of IL-8, monocyte chemoattractant protein
(MCP)-1, fatty acid binding protein (FABP)4 and adipocyte size in the adipose tissue. These
are markers for either adipose tissue inflammation or adipocyte health. The tissue samples
were collected after written informed consent from all individual participants, and the protocol
was approved by the ethical committee of the Radboud University Nijmegen Medical Centre
and in accordance with the Declaration of Helsinki.
Stromal vascular and mature adipocyte fractions
The collected SAT and VAT samples were disaggregated using collagenase type 1 (Gibco, Life
Technologies) digestion to isolate adipocytes and the stromal vascular fraction (SVF) as de-
scribed before [21]. Purity of the two different fractions was confirmed using FABP 4 (adipo-
cytes), and CD45 (hematopoietic cells) (S1 Table). The cellular fractions were subsequently
used for RNA isolation, followed by real-time PCR analysis, as described below.
Histochemistry
Morphometry of individual fat cells was assessed using digital image analyses as described pre-
viously [22]. In short: for each subject, the adipocyte cell diameter of all fat cells in five to ten
microscopic fields of view were counted and measured. For detection of crown-like structures,
a CD68 antibody (AbD Serotec, Oxford, UK) was used in human samples. In mouse samples,
an antibody against F4/80+ (AbD Serotec, Oxford, UK) was used. Visualization of the complex
was done using 3,3’-diaminobenzidene for 5 min. Negative controls were used by omitting the
primary antibody.
Animals
16 Male TLR-3-/- and 20 male WT mice on a C57Bl/6 background were obtained from Jack-
sons Laboratory and housed in a pathogen-free environment in the animal facility of the Rad-
boud University, Nijmegen. The mice were purchased at Jackson and housed individually in
filter top cages in a separate room, with water and food ad libitum. The housing temperature
was held at 23°C and a 12:12h light-dark cycle was maintained. After a 1-week run-in period
on a low-fat diet, the mice were divided in a low-fat diet (LFD) and a high-fat diet (HFD)
group. The diet contained either 10% or 45% energy derived from fat, lard-oil was replaced by
palm-oil (D12450B or 12451; Research Diet Services, Wijk bij Duurstede, The Netherlands).
This diet was continued for 16 weeks. Bodyweight of the animals was recorded weekly. After
sacrifice, liver and epididymal adipose tissue weight were measured. All animal procedures
were conducted under protocols approved by the animal experimentation committee of Rad-
boud University Medical Centre, Nijmegen.
Insulin tolerance test (ITT)
An insulin tolerance test was performed after a 4 hours fasting period. 0,75 U of insulin per ki-
logram bodyweight was injected intraperitoneally. Blood glucose levels were determined with
an Accu-chek glucosemeter (Roche Diagnostics, Almere, The Netherlands) at indicated time
points after insulin administration.
qPCR
Total RNA was isolated from adipose tissue using TRIzol (Invitrogen, Carlsbad, CA), accord-
ing to manufacturer’s instructions. RNA was reverse-transcribed (iScript cDNA Synthesis Kit,
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Bio-Rad Laboratories). RT-PCR was performed using specific primers (see S2 Table), power
SYBR green master mix (Applied Biosystems, Foster City, CA) using the Step-one Real-Time
PCR system (Applied Biosystems, Foster City, CA). For mice samples, we used 36B4 as house-
keeping gene. For human samples we used B2M as a housekeeping gene.
Insulin
Insulin levels in humans were measured by the clinical laboratory unit of the Radboud Univer-
sity Medical Centre, Nijmegen.
Plasma glucose
Glucose (Liquicolor, Human GmbH, Wiesbaden, Germany) was measured enzymatically fol-
lowing manufacturers’ protocols.
Cell lines
Human Simpson-Golabi-Behmel syndrome (SGBS) preadipocytes were cultured as described
earlier [23]. After full differentiation cells were treated with poly(I:C) 12.5 μg/ml or lipopoly-
saccharide 50 ng/ml to stimulate respectively TLR-3 or TLR-4.
Western Blot
Human subcutaneous adipose tissue samples were analysed for TLR-3 expression. Lysates pre-
pared using a lysis buffer [50mM Tris (pH7.4), 150mMNaCl, 2mMEDTA,1%Nonidet P-40,
50mMNaF,and 0.25% sodium deoxycholate with phosstop phosphatase-inhibitor cocktail tab-
let (Roche) and complete, EDTA-free protease-inhibitor cocktail tablet (Roche). The homoge-
nate was centrifuged at 4°C for 10 min at 18.000 rcf and the supernatant was used for Western
blot analysis. Equal amounts of protein, as determined by a BCA protein assay (Thermo Fish-
erScientific, Rockford, IL) were separated using a polyacrylamide SDS page gel. After
SDS-PAGE, proteins were transferred to a nitrocellulose membrane using a Trans-Blot Turbo
Transfer System (Biorad) following manufacturer’s instructions. The membrane was blocked
with 5% (wt/vol) milk powder in Tris-buffered saline (TBS)/Tween 20 for 1 h at room tempera-
ture followed by incubation overnight at 4 C with a TLR-3 antibody (Abcam, ab62566), in 5%
(wt/vol) milk powder/TBS/Tween 20. After overnight incubation, the blots were incubated
with horseradish peroxidase-conjugated secondary antibody (goat anti-rabbit, A0545, Sigma
Aldrich) at a dilution of 1:5000 in 5% (wt/vol) milk powder in TBS/Tween 20 for 1 h at room
temperature and subsequently developed with ECL plus (Thermo Scientific) according to the
manufacturer’s instructions. Bands were visualized using a ChemiDoc System (Biorad) and
quantified using Image lab software (Biorad).
Small interfering RNA
To specifically suppress TLR-3 expression in differentiated adipocytes, cells were transfected
(X-tremeGENE siRNA Transfection Reagent, Roche) with small interfering (si)RNA against
TLR-3 (Thermo Scientific). As a nonspecific control, scrambled siRNA (Thermo Scientific)
was used. After 72 hours of incubation, gene expression was determined.
Statistical analysis
Data are shown as means ± SEM. Differences between groups were analyzed using Student’s
t test, differences among 4 groups were analyzed with ANOVA followed by post-hoc
TLR-3 and Obesity
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Bonferroni tests and correlations were evaluated with regression analysis in Graphpad Prism
6.0. p-values<0.05 were considered significant.
Results
TLR-3 is highly expressed in adipocytes and functionally active
We investigated expression patterns of all TLR-family members in human adipose tissue. Adi-
pose tissue biopsies of both subcutaneous and visceral depots were used and separated in stro-
mal vascular fraction (SVF) and mature adipocytes (MA). Separation of adipocyte and stromal
vascular fraction was adequate as determined by expression of CD45 and FABP4 in the two
fractions (S1a/S1b Fig). Most TLR-family members were more robustly expressed in the SVF
fraction compared to the MA fraction (e.g. TLR-1, TLR-2), or similarly expressed between the
SVF and MA fraction (e.g. TLR-6, TLR-7, TLR-8). Remarkably, the expression profile of TLR-
3 was different from the expression pattern observed for the other TLRs, as it was significantly
higher expressed in the MA fraction compared to SVF (Fig 1a). The only additional receptor
that was relatively high expressed in adipocytes was TLR-5. However, its expression was just 4
times higher in only the visceral adipocytes compared to the stromal vascular cells, where TLR-
3 had a 6-fold higher expression in adipocytes. This difference was apparent for both subcuta-
neous and visceral adipose tissue. Moreover, TLR-3 protein expression in human subcutaneous
adipose tissue was confirmed by Western Blot (S1c Fig). Additionally, we found that TLR-3
was highly induced during differentiation of SGBS adipocytes in vitro (Fig 1b), in a similar
fashion as PPAR-γ, a marker for adipocyte differentiation (Fig 1c).
Next, we tested whether TLR-3 activation in adipocytes was functionally active. Therefore,
we treated differentiated adipocytes with poly(I:C), a synthetic TLR-3 ligand and compared
this to E.coli LPS, a TLR-4 ligand. Similar to LPS, poly(I:C) significantly increased transcription
of pro-inflammatory cytokine IL-8 after 24 hours. In addition, poly(I:C) induced expression of
MCP-1, a key molecule that mediates macrophage infiltration in adipose tissue [24], while IL-
1β expression was not increased after 24 hours of LPS or poly(I:C) treatment. Furthermore,
adipogenic genes adiponectin and PPARγ were significantly decreased after Poly(I:C) stimula-
tion (Fig 2a).
To ensure that the effects of poly(I:C) on adipogenic and pro-inflammatory cytokine gene
expression were specifically mediated by TLR-3, the expression of TLR-3 was blocked using
small interfering RNA (siRNA). TLR-3 was blocked with a knockdown of almost 75% (S2 Fig).
These data reveal that poly(I:C) increased expression of IL-8 and MCP-1 in a TLR-3 dependent
manner, since blockage of TLR-3 with siRNA greatly inhibited the poly(I:C) mediated induc-
tion of these genes (Fig 2b and 2c). Gene expression levels of IL-1β were unaffected (Fig 2d). In
contrast, downregulation of adiponectin and PPARγ was not affected by blockage of TLR-3,
suggesting that other signalling routes besides TLR-3 are likely to play a role in down-
regulating adipogenesis upon Poly(I:C) stimulation (Fig 2e and 2f).
TLR-3 deficiency does not affect weight gain or insulin sensitivity after
HFD-feeding
To test whether TLR-3 is functionally relevant in the process of diet induced obesity and insu-
lin resistance, TLR-3-/- mice and WT controls were fed a HFD for 16 weeks. TLR-3 deficiency
did not influence HFD-induced obesity, compared to WTmice (Fig 3a). Similarly, liver and ep-
ididymal adipose (eWAT) tissue weights were not statistically different in TLR-3-/-mice as
compared to WT animals (Fig 3b and 3c). The latter was confirmed by a similar increase of
plasma leptin levels in both genotypes due to HFD feeding (Fig 3d). Next, we tested whether
TLR-3 and Obesity
PLOS ONE | DOI:10.1371/journal.pone.0123152 April 13, 2015 5 / 14
TLR-3-/- mice were protected from HFD-induced insulin resistance. Fasting glucose levels
(8 hours) were similar in both genotypes, after LFD and HFD-feeding (Fig 3e). An insulin tol-
erance test performed 15 weeks after starting the diet intervention showed a tendency towards
a reduction in insulin sensitivity in HFD-fed TLR-3-/- mice, however this difference did not
reach statistical (Fig 3f and 3g).
TLR-3 deficiency does not influence obesity-induced adipose tissue
inflammation in mice
In a following set of experiments, we assessed whether TLR-3 deficiency affected the develop-
ment of obesity-induced adipose tissue inflammation. Therefore, histological sections of
eWAT were stained with F4-80, a macrophage marker (Fig 4a). No differences were found in
the number of crown-like structures between TLR-3-/- and WT animals (Fig 4b). This result
was confirmed by similar gene expression levels of two macrophage markers, F480 and CD68,
Fig 1. TLR-3 is predominantly expressed in adipocytes. (a) Biopsies from visceral- (VAT) and
subcutaneous adipose tissue (SAT) were obtained from 4 healthy subjects and TLR expression was
determined in stromal vascular fraction (SVF) and mature adipocytes (MA). mRNA levels of (b) TLR-3 and (c)
PPAR-γ were measured during differentiation of human SGBS adipocytes. * p<0.05, ** p<0.01. Data are
shown as means ± SEM.
doi:10.1371/journal.pone.0123152.g001
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as detected by qPCR analysis (Fig 4c and 4d). Only monocyte chemoattractant protein (MCP)-
1 was slightly higher expressed in the absence of TLR-3 (Fig 4e). Together, these data suggest
that TLR-3 deficiency does not affect macrophage infiltration. Additionally, we did not find
differences in macrophage activation as determined by expression of the pro-inflammatory cy-
tokines TNFα and CXCL1 in adipose tissue of TLR-3-/- and WTmice, (Fig 4f and 4g). Inter-
estingly, TLR-3 expression itself was not different between HFD- and LFD-treated WTmice
(Fig 4h), while expression of other TLRs was upregulated (TLR-6) or tended to increase (TLR-
1 and TLR-2) in response to HFD, except for TLR-4 (S3a–S3d Fig). However, expression of
these TLRs was not different between TLR-3-/- and WT mice fed either a LFD or a HFD,
Fig 2. TLR-3 is functionally active in adipocytes. (a) Differentiated SGBS adipocytes were stimulated with either a TLR-3 (poly:IC 12.5μg/ml) or TLR-4
(LPS 50ng/ml) agonist. mRNA levels were measured for IL-8, MCP-1, IL-1 β, adiponectin and PPAR-γ. (b-f) SGBS adipocytes were treated with SiRNA
against TLR-3 or scr SiRNA and stimulated with poly:IC. mRNA levels of (b) IL-8, (c) MCP-1, (d) IL-1β, (e) adiponectin, (f) PPAR- γ were subsequently
measured. * p<0.05, ** p<0.01, *** p<0.001. Data are shown as means ± SEM.
doi:10.1371/journal.pone.0123152.g002
TLR-3 and Obesity
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revealing no compensatory up-regulation of other TLRs in adipose tissue in the absence of
TLR-3. Furthermore, expression of 9 TLRs in chow fed mice was measured in stromal vascular
cells compared to mature adipocytes (S4 Fig). Most TLRs, except 2, 4 and 5 were more express-
ed in stromal vascular cells. Thus TLR-3, opposed to human adipose tissue, displayed a lower
expression level in mouse adipocytes.
TLR-3 in human subcutaneous adipose tissue
Next, we correlated the gene expression levels of TLR-3 in subcutaneous adipose tissue samples
from 80 healthy donors, with markers of obesity, inflammation and insulin sensitivity. TLR-3
expression in subcutaneous adipose tissue was similar between lean and obese individuals
(Fig 5a). Similarly, no difference in TLR-3 expression was observed between subjects with high
insulin sensitivity levels versus low insulin sensitivity levels, as determined by the homeostatic
model assessment for insulin resistance (HOMA-IR) (Fig 5b). Subjects with higher systemic in-
flammation (high sensitive C-reactive protein (hs-CRP) levels) or increased adipose tissue in-
flammation (number of crown-like structures) also showed an equal expression of TLR-3 (Fig
5c and 5d). In contrast, we found that adipose tissue of subjects with higher expression of the
pro-inflammatory cytokine IL-8 showed a tendency for lower mRNA levels of TLR-3 (Fig 5e).
A similar tendency was seen for MCP-1 and TLR-3 expression (Fig 5f). On the contrary,
FABP4 showed a positive association with TLR-3 expression in adipose tissue (Fig 5g), al-
though this did not reach statistical significance. Finally, despite a high expression of TLR-3 in
mature adipocytes, its expression did not associate with mean adipocyte cell size in adipose tis-
sue (Fig 5h).
Fig 3. TLR-3 deficiency does not protect mice against metabolic abnormalities.Wild-type (WT) and TLR-3-/- mice were subjected to 16 weeks of low fat
diet (LFD) or high fat diet (HFD). (a) development of the bodyweight, (b) liver weight, (c) epididymal adipose tissue weight, (d) plasma leptin levels, (e) fasting
glucose levels, (f) insulin tolerance test (ITT), (g) area under the curve for ITT. * p<0.05, *** p<0.001. Number of mice per group: WT-LFD n = 10; WT-HFD
n = 10; TLR-3-/-LFD n = 7; TLR-3-/-HFD n = 9. Data are shown as means ± SEM.
doi:10.1371/journal.pone.0123152.g003
TLR-3 and Obesity
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Discussion
Innate pattern recognition receptors (PRRs) are increasingly recognized as direct or indirect
sensors of excessive nutrients instigating a chronic inflammatory response in adipose tissue
during obesity, with possibly detrimental effects on insulin sensitivity levels [10]. During this
metaflammation [7], the function of TLR-3, stimulated by double-stranded mRNA and yield-
ing production of type-1 Interferons [19], remains largely unknown. In the current study we
examined whether TLR-3-signalling is involved in the development of adipose tissue inflam-
mation and insulin resistance during the development of obesity. To study a potential role of
TLR-3 triggered by its remarkable high expression in adipocytes, as compared to other mem-
bers of the TLR family. We show that TLR-3 is active in adipocytes upon stimulation with spe-
cific ligands. However, TLR-3-/- mice showed no significant amelioration in adipose tissue
inflammation and insulin sensitivity after HFD-feeding. Additionally, data obtained from 80
human adipose tissue biopsies showed a limited association of TLR-3 gene expression levels
with various metabolic abnormalities including insulin resistance and adipose tissue inflamma-
tion. Together, these data suggest that although TLR-3 is predominantly expressed in
Fig 4. TLR-3 deficiency does not ameliorate adipose tissue inflammation. After 16 weeks of low fat diet (LFD) or high fat diet (HFD) intervention, adipose
tissue of wild-type (WT) and TLR-3-/- mice was investigated for inflammatory parameters. (a) Adipose tissue of mice stained for F4/80, magnification 20x, (b)
number of crown-like structures in adipose tissue. Inflammatory markers were measured (c) F480, (d) CD68, (e) MCP-1, (f) TNFα, (g) CXCL1. (h) mRNA
levels of TLR-3 in WTmice fed a LFD or HFD for 16 weeks. * p<0.05, ** p<0.01. Number of mice per group: WT-LFD n = 10; WT-HFD n = 10; TLR-3-/-LFD
n = 7; TLR-3-/-HFD n = 9. Data are shown as means ± SEM.
doi:10.1371/journal.pone.0123152.g004
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adipocytes and functionally active, it has a limited role in mediating 16 weeks HFD-induced
adipose tissue inflammation and systemic insulin sensitivity in mice, nor a profound associa-
tion with metabolic abnormalities in humans.
Interestingly, TLR-3 is preferentially expressed on adipocytes as compared to stromal vascu-
lar cells suggestive of a functional role of the receptor specifically in these cells. Indeed, our
data demonstrate that stimulation of TLR-3 increases pro-inflammatory cytokine expression,
an effect that was abolished by silencing of TLR-3 in adipocytes using siRNA. Thereby, we con-
firm that adipocytes can produce cytokines after specific TLR-3 stimulation [25]. Moreover,
TLR-3 was up-regulated during differentiation of adipocytes. The high expression levels led us
to believe that TLR-3 may exert a more dominant role in adipose tissue as compared to other
TLR-family members.
However, despite its prominent expression and function in adipocytes, in vivo studies using
TLR-3-/- mice revealed no amelioration in adipose tissue inflammation or insulin sensitivity
levels as compared to WT mice after 16 weeks of HFD-feeding. The difference in expression
pattern of TLR-3 in adipocytes vs stromal vascular fraction between mouse and human adipose
tissue may explain at least some of our apparent conflicting observations between in vitro and
in vivo results. In addition, we observed a different effect of TLR-3 deficiency on MCP-1 ex-
pression between the in vitro and in vivo experiments. These divergent responses may be ex-
plained by differences in model-complexity or a different response to TLR-3 signalling in
human versus murine cells [26].
Our in vivo results are partly in contrast to a recent report demonstrating that the absence
of TLR-3 or its blockage using a specific antibody led to improvements in glucose tolerance
[27]. However, in line with our results, a glucose tolerance test performed by Wu et al after 14
weeks of HFD revealed no differences between WT and TLR-3-/- animals compared to WT
mice. Only after 26 weeks of HFD-feeding, the absence of TLR-3 led to an improvement in glu-
cose tolerance. Moreover, the absence of TLR-3 protected against the development of hepatic
steatosis after 33 weeks of HFD and reduced expression levels of TNFα in liver. Our research
Fig 5. TLR-3 in human adipose tissue. Subcutaneous adipose tissue samples of 80 healthy individuals were obtained. TLR-3 mRNA levels were
associated with (a) BMI, (b) HOMA-IR, (c) plasma CRP-levels, (d) number of crown-like structures in adipose tissue. Association of MAP3K8mRNA
expression in human subcutaneous adipose tissue with mRNA expression of (e) IL-8, (f) MCP-1, (g) FABP4 and (h) adipocytes cell size. * p<0.05. Data are
shown as means ± SEM. HOMA-IR = Homeostatic Model Assessment for insulin resistance.
doi:10.1371/journal.pone.0123152.g005
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advances these studies by specifically focussing on establishing a role for TLR-3 in adipose tis-
sue. Possibly, TLR-3 exerts differential effects in the liver versus adipose tissue during the de-
velopment of HFD-induced obesity. More likely, the opposite outcomes are explained by
differences in study design. The diet intervention in our study was done using a low fat diet
and high fat diet containing 45% of energy derived from fat. Wu et al used a high fat diet with
60% of energy from fat with chow diet as control feeding. Additionally, the intervention period
lastly for a total period of 33 weeks whereas our study design included only 16 weeks of HFD-
feeding.
Hence, these outcomes may suggest that the absence of TLR-3 ameliorates metabolic abnor-
malities induced by high fat diet feeding only after a prolonged time of diet intervention. One
might speculate that the ligand responsible for activation of TLR-3 only becomes available after
long term and very high fat diet feeding.
Although many TLRs have both endogenous and exogenous stimuli, the endogenous activa-
tor of TLR-3 remains to be established. Based on current knowledge, TLR-3 primary function
is to recognize double stranded RNA and contributes to the host defence against viruses. What
type of endogenous activator in adipose tissue might propel TLR-3 activation is currently un-
known, however it has been shown that TLR-3 also recognizes single-stranded mRNA [18]. In
obesity, dying adipocytes may therefore release mRNA, which is then recognized by TLR-3.
However, in spite of its high expression levels in human adipocytes that may suggest otherwise,
our results do not provide evidence for a vital, important role of TLR-3 in adipose tissue during
diet-induced obesity. The high expression of TLR3 in the adipocyte fraction of human adipose
tissue, however, suggest a possible other role in human adipocyte function. Recently, it was dis-
covered that activation of TLR-3 reduces adipocyte differentiation [28] and that this resulted in
inhibited insulin and glucose signalling [29]. As TLR-3 may be involved in the recognition of
dying adipocytes, the necrotic cells may thereby directly influence surrounding pre-adipocytes
and inhibit their differentiation and suppress glucose and insulin signalling. Moreover, al-
though especially TLR-2 and TLR-4 have been implicated in mediating the pro-inflammatory
actions of free fatty acids, we cannot rule out that TLR-3 mediates some of these free fatty acids
related effects.
As it is hypothesised that viruses play a role in the pathogenesis of type 1 diabetes, it might
be interesting to investigate the role of TLR-3 in the pancreas. Several studies have showed a
link between TLR-3 induced islet inflammation and type 1 diabetes (22–24). Because 16 weeks
is not long enough to induce islet inflammation in mice in contrary to adipose tissue inflamma-
tion, our study was able to investigate the effects of TLR-3 without confounding effects of
the pancreas.
In line with the results from the animal study that did not reveal a vital role for TLR-3 in
mediating obesity-induced inflammation and the development of insulin resistance, the func-
tion of the receptor in human adipose tissue appears to be relatively small. However, as shown
in literature [27], TLR-3 may exacerbate metabolic abnormalities in the liver after 33 weeks of
HFD in mice as opposed to adipose tissue. Moreover, we observed no clear associations in hu-
mans, suggesting that TLR-3 has a limited role in mediating adipose tissue inflammation and
the development of insulin resistance. However, these results do not completely rule out any
function of TLR-3-signalling in adipose tissue during the presence of obesity. Noticeably, our
results were obtained using subcutaneous adipose tissue biopsies and not the metabolically
more active visceral depot. In addition to gene expression levels, future studies should also de-
termine the activity of TLR-3-dependent signalling routes within adipose tissue by measuring
TLR-3 protein levels and possible intracellular downstream targets.
Altogether, these data show that TLR-3 is highly expressed in adipocytes as compared to the
stromal vascular cells and is functionally active. Nevertheless, in mice after 16 weeks of HFD
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and in humans, the data does not support a fundamental role for TLR-3 in the development of
obesity-induced adipose tissue inflammation and insulin resistance.
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